U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 21:41:08 GMT 2025
Edited
by admin
on Tue Apr 01 21:41:08 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED
Sequence Type COMPLETE
Record UNII
AE72RB1W1X
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
Zenocutuzumab
USAN   INN  
Official Name English
MCLA-128
Preferred Name English
ZENOCUTUZUMAB [USAN]
Common Name English
MCLA128
Code English
Immunoglobulin G1, bispecific, anti-(human epidermal growth factor receptors, HER2 and HER3) (humanized clone MCLA-128 ?1-chain), disulfide with humanized clone MCLA-128 light chain, dimer
Common Name English
Zenocutuzumab [WHO-DD]
Common Name English
Immunoglobulin G1-kappa, anti-(Homo sapiens Receptor tyrosine-protein kinase erbB-3 (Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, EC=2.7.10.1)) and anti-(Homo sapiens Receptor tyrosine-protein kinase erbB-2 (Meta
Common Name English
MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)
Common Name English
zenocutuzumab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 750020
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
Code System Code Type Description
CAS
1969309-56-5
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
NCI_THESAURUS
C152948
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
DRUG BANK
DB15559
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
USAN
HI-231
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
SMS_ID
300000025314
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
FDA UNII
AE72RB1W1X
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
INN
10687
Created by admin on Tue Apr 01 21:41:08 GMT 2025 , Edited by admin on Tue Apr 01 21:41:08 GMT 2025
PRIMARY
From To
1_22 1_96
1_151 1_207
1_268 1_328
1_374 1_432
2_22 2_96
2_148 2_204
2_265 2_325
2_371 2_429
1_227 3_214
1_233 2_230
1_236 2_233
2_224 4_214
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN, AFUCOSYLATED
Glycosylation Link Type Site
N 1_304
N 2_301
Related Record Type Details
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
IgG1 bispecific antibody with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity targeting HER2 and HER3 receptors.
TARGET -> INHIBITOR
IgG1 bispecific antibody with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) activity targeting HER2 and HER3 receptors.
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL